Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Apremilast did not work for treating severe alopecia areata.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Abatacept may help some people with alopecia areata regrow hair.

Dupilumab effectively treated severe alopecia areata in a child.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Higher IL-21 levels may help predict alopecia areata activity.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Blocking LFA-1 prevents hair loss in mice.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Candida antigen is an effective and promising treatment for alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.